Show simple item record

2021Zeitschriftenartikel
The COVID-19 Disease Burden in Germany in 2020
dc.contributor.authorRommel, Alexander
dc.contributor.authorvon der Lippe, Elena
dc.contributor.authorPlaß, Dietrich
dc.contributor.authorZiese, Thomas
dc.contributor.authorHeiden, Matthias an der
dc.contributor.authorHaller, Sebastian
dc.contributor.authorWengler, Annelene
dc.date.accessioned2024-07-23T15:33:14Z
dc.date.available2024-07-23T15:33:14Z
dc.date.issued2021none
dc.identifier.other10.3238/arztebl.m2021.0147
dc.identifier.urihttp://edoc.rki.de/176904/11820
dc.description.abstractBackground: The SARS-CoV-2 pandemic presented major challenges to the health sector in 2020. The burden of disease arising from COVID-19 can be expressed as the number of years of life lost to disease or death. For example, death at age 40 involves a loss of far more years of life than death at age 80. Methods: The disability-adjusted life years (DALY) lost to COVID-19 were calculated as the sum of the years of life lost through death (YLL) and the number of years lived with disability (YLD), on the basis of laboratory-confirmed notifiable cases of SARS-CoV-2 infection in Germany in 2020 (documented as of 18 January 2021). The methodology was based on that used in the Global Burden of Disease Study. Pre-existing diseases do not enter into the determination of YLL; rather, the residual life expectancy that is applied in this calculation corresponds to a mean age-specific level of morbidity. Results: 305 641 years of life were lost to COVID-19 in Germany in 2020. The percentage of DALY lost by persons under 70 was 34.8% in men and 21.0% in women. 99.3% of the COVID-19 disease burden was accounted for by death (YLL). The daily average years of life lost due to death was lower for COVID-19 than for the major non-communicable diseases. Persons who died of COVID-19 lost a mean of 9.6 years of life; those who were under 70 when they died lost a mean of 25.2 years of life. Men lost more years of life than women (11.0 vs. 8.1 years). Conclusion: The effects of COVID-19 on public health can be expressed through the burden of disease indicators. This method yields additional information that should be put to use early in the course of future outbreaks.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleThe COVID-19 Disease Burden in Germany in 2020none
dc.typearticle
dc.identifier.urnurn:nbn:de:0257-176904/11820-5
dc.type.versionpublishedVersionnone
local.edoc.container-titleDeutsches Ärzteblattnone
local.edoc.container-issn0012-1207none
local.edoc.pages23none
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.aerzteblatt.de/none
local.edoc.container-publisher-nameDeutscher Ärzteverlag GmbHnone
local.edoc.container-volume118none
local.edoc.container-reportyear2021none
dc.description.versionPeer Reviewednone

Show simple item record